Literature DB >> 2625215

Variation in retinal changes and muscle pathology in mitochondriopathies.

J Bosche1, W Hammerstein, E Neuen-Jacob, R Schober.   

Abstract

A variety of retinal changes that have so far not been classified under mitochondriopathies can now be included in this group, since muscle biopsy has identified ragged-red fibers with pathological mitochondriae. The ophthalmological findings in our relatively large group of 12 patients with mitochondrial myopathies are compared with the spectrum of myopathic findings. No obvious correlation exists between the severity of the pathological retinal changes and the characteristic of the myopathic alterations. In addition to fine pigmentation and depigmentation, severe dystrophic changes of the retina, pigment epithelium, and the choroid were observed. In two patients with severe chorioretinal dystrophy the correlation with generalized mitochondriopathy was not suspected prior to muscle biopsy.

Entities:  

Mesh:

Year:  1989        PMID: 2625215     DOI: 10.1007/bf02169456

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  33 in total

1.  Partial cytochrome oxidase (aa3) deficiency in chronic progressive external ophthalmoplegia. Histochemical and biochemical studies.

Authors:  E Byrne; X Dennett; I Trounce; R Henderson
Journal:  J Neurol Sci       Date:  1985-12       Impact factor: 3.181

2.  Ophthalmoplegia plus with morphological and chemical studies of cerebellar and muscle tissue.

Authors:  L Schneck; M Adachi; P Briet; A Wolintz; B W Volk
Journal:  J Neurol Sci       Date:  1973-05       Impact factor: 3.181

3.  Ophthalmoplegia plus. The neurodegenerative disorders associated with progressive external ophthalmoplegia.

Authors:  D A Drachman
Journal:  Arch Neurol       Date:  1968-06

4.  [Clinical, morphological and biochemical findings in the Kearns-Sayre syndrome].

Authors:  W Hammerstein; W Mortier; E A Noack; H Frenzel; U G Liebert; K Toyka; D Horstkotte; G Bischof; U Weber
Journal:  Fortschr Ophthalmol       Date:  1983

5.  Kearns syndrome: a heterogeneous group of disorders with CPEO, or a nosological entity?

Authors:  L A Bastiaensen; C W Frenken; H J Ter Laak; H H Jaspar; A M Stadhouders; W Ruitenbeek; J H Veerkamp
Journal:  Doc Ophthalmol       Date:  1982-01-29       Impact factor: 2.379

6.  Kearns syndrome or Kearns disease. Further evidence of a genuine entity in a case with uncommon features.

Authors:  L A Bastiaensen; S L Notermans; C H Ramaekers; B J van Dijke; E M Joosten; H H Jaspar; A M Stadhouders; C T Beljaars
Journal:  Ophthalmologica       Date:  1982       Impact factor: 3.250

7.  Clinical features of mitochondrial myopathy.

Authors:  E Byrne; P C Blumbergs; J F Hallpike; T M Mukherjee
Journal:  Aust N Z J Med       Date:  1983-08

8.  Treatment of Kearns-Sayre syndrome with coenzyme Q10.

Authors:  S Ogasahara; Y Nishikawa; S Yorifuji; F Soga; Y Nakamura; M Takahashi; S Hashimoto; N Kono; S Tarui
Journal:  Neurology       Date:  1986-01       Impact factor: 9.910

9.  Autosomal dominant Kearns-Sayre syndrome.

Authors:  A S Leveille; F W Newell
Journal:  Ophthalmology       Date:  1980-02       Impact factor: 12.079

10.  Hyperglycemic acidotic coma and death in Kearns-Sayre syndrome.

Authors:  B N Bachynski; J T Flynn; M M Rodrigues; S Rosenthal; R Cullen; R G Curless
Journal:  Ophthalmology       Date:  1986-03       Impact factor: 12.079

View more
  2 in total

1.  Cone and rod dysfunction in the NARP syndrome.

Authors:  I Chowers; T Lerman-Sagie; O N Elpeleg; A Shaag; S Merin
Journal:  Br J Ophthalmol       Date:  1999-02       Impact factor: 4.638

2.  Retinitis pigmentosa, ataxia, and mental retardation associated with mitochondrial DNA mutation in an Italian family.

Authors:  P Puddu; P Barboni; V Mantovani; P Montagna; A Cerullo; M Bragliani; C Molinotti; R Caramazza
Journal:  Br J Ophthalmol       Date:  1993-02       Impact factor: 4.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.